{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:50:31Z","timestamp":1761173431129,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.purol.2009.01.006","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T04:26:07Z","timestamp":1239769567000},"page":"558-562","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effet du traitement par l\u2019oxybutynine en sublingual dans les douleurs postop\u00e9ratoires apr\u00e8s prostatectomie totale"],"prefix":"10.1016","volume":"19","author":[{"given":"C.","family":"Callier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tauzin-Fin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ballanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2009.01.006_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/bja\/75.2.132","article-title":"Visceral pain","volume":"75","author":"McMahon","year":"1995","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.purol.2009.01.006_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0094-0143(02)00175-1","article-title":"Practical considerations in radical retropubic prostatectomy","volume":"30","author":"Lepor","year":"2003","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.purol.2009.01.006_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1469-445X.1999.tb00083.x","article-title":"Advances in the pharmacological control of the bladder","volume":"14","author":"Andersson","year":"1999","journal-title":"Exp Physiol"},{"key":"10.1016\/j.purol.2009.01.006_bib4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0025-6196(11)62382-3","article-title":"Prospective randomized controlled trial of extended release oxybutybin chloride and tolterodine in the treatmentof over active bladder: results of the OBJECT study","volume":"76","author":"Appell","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.purol.2009.01.006_bib5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/01.ane.0000167775.46192.e9","article-title":"The efficacy of tolterodine for prevention of catheter related bladder discomfort: a prospective randomized placebo-controlled double blind study","volume":"101","author":"Agarwal","year":"2001","journal-title":"Anesth Analg"},{"key":"10.1016\/j.purol.2009.01.006_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(00)02688-3","article-title":"Role of spinal alpha(1)-adrenergic mechanisms in the control of lower urinary tract in the rat","volume":"882","author":"Yoshiyama","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.purol.2009.01.006_bib7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/00003495-199958050-00002","article-title":"Balanced analgesia: what is it and what are its advantages in postoperative pain","volume":"58","author":"Kehlet","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.purol.2009.01.006_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s003450100226","article-title":"Which muscarinic receptor is important in the bladder","volume":"19","author":"Yamanishi","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2009.01.006_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0090-4295(99)00493-8","article-title":"Functionnal role of M1, M2 and M3 muscarinic receptors in over active bladder","volume":"55","author":"Igawa","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.01.006_bib10","first-page":"773","article-title":"Rapport\u00a0: incontinence urinaire de la femme. \u00c9valuation et traitement. Chapitre 4\u00a0: incontinence urinaire d\u2019origine v\u00e9sicale - instabilit\u00e9 v\u00e9sicale","volume":"5","author":"Ballanger","year":"1995","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2009.01.006_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yanker","year":"1995","journal-title":"Drug Aging"},{"key":"10.1016\/j.purol.2009.01.006_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of over active bladder","volume":"55","author":"Chapple","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.purol.2009.01.006_bib13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/bja\/ael003","article-title":"Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter bladder discomfort: a prospective, randomized, placebo controlled double-blind study","volume":"96","author":"Agarwal","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.purol.2009.01.006_bib14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-5347(01)65148-6","article-title":"Comparison of oxybutynin and its active metabolite N-desethyl-oxybutynin in the human detrusor and parotid gland","volume":"157","author":"Waldeck","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2009.01.006_bib15","first-page":"660","article-title":"Int\u00e9r\u00eat de l\u2019oxybutynine en instillation intrav\u00e9sicale dans les hyperactivit\u00e9s v\u00e9sicales rebelles. \u00c9tude de 15patients","volume":"2","author":"Amarenco","year":"1992","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2009.01.006_bib16","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1100\/tsw.2007.271","article-title":"The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury","volume":"7","author":"George","year":"2007","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.purol.2009.01.006_bib17","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1517\/14656566.4.12.2315","article-title":"Transdermal oxybutynin: a new treatment for over active bladder","volume":"4","author":"Davila","year":"2003","journal-title":"Expert Opin Pharmacother"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708709000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708709000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:17:01Z","timestamp":1761113821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708709000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S1166708709000293"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2009.01.006","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effet du traitement par l\u2019oxybutynine en sublingual dans les douleurs postop\u00e9ratoires apr\u00e8s prostatectomie totale","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2009.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}